Track how drugs, trials and regulatory decisions develop.
Trial changes · Clinical results · Regulatory decisions · Safety updates
Which drugs, companies, trials, and healthcare markets are showing early signs of progress, risk, or change?
Clinical and regulatory records reveal milestones, setbacks, safety signals and access changes as they occur, creating a point-in-time history of drug development and market access.
Which programs are advancing, weakening, or nearing a catalyst?
Trials, FDA filings, disclosures, endpoints, and indications.
When will this read out, and will it slip?
Trial status, enrollment, completion dates, and endpoint changes.
Will this clear the FDA, and on what timeline?
Approvals, CRLs, advisory committees, designations, and labels.
Is this commercially viable, and is a safety signal forming?
CMS and payer decisions, pricing, FAERS, and post-market records.
Expert-grade analysis for the most critical decisions, benchmarked head-to-head against frontier models.
Read the benchmarkApply your lens.
Follow the drugs, trials and sponsors your team covers. Connect each development to its history and source evidence for news, research and analytics.
- Clinical trial registries
- FDA actions
- Sponsor disclosures
- Endpoints & indications
- Labels
- Safety records
- Market access decisions
- Payer policies
- Provider datasets
- Hospital financials
- Utilization files
- Post-market obligations
See it running on your desk.
Review a drug’s development history, with trial changes and regulatory events linked to their sources.